[Other] Antiangiogenic每immune-checkpoint inhibitor combinations: lessons from phase III clinical trials

Snur Post time 2026-10-19 23:12:31 | Show all posts |Read mode
This post will be closed automatically in 2026-10-22 23:11
Reward20points



DOI: 10.1038/s41571-024-00886-y
https://www.nature.com/articles/s41571-024-00886-y



Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
jakir_ete_ruet Post time 2026-10-19 23:12:32 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Snur Post time 2026-10-19 23:18:17 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    60


Daily Top Contributors

Return to the list